ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,137.73
0.20%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Xenon Pharmaceuticals Inc (XENE)

  7. Xenon Pharmaceuticals Inc (XENE) News

Xenon Pharmaceuticals (XENE)

Xenon Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:XENE
DateTimeSourceHeadlineSymbolCompany
12/06/202422:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202422:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202422:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202422:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202422:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202422:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202421:22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202421:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202421:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:XENEXenon Pharmaceuticals Inc
28/05/202413:30GlobeNewswire Inc.Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual MeetingNASDAQ:XENEXenon Pharmaceuticals Inc
09/05/202421:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XENEXenon Pharmaceuticals Inc
09/05/202421:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XENEXenon Pharmaceuticals Inc
09/05/202421:01GlobeNewswire Inc.Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
08/05/202421:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024NASDAQ:XENEXenon Pharmaceuticals Inc
07/05/202421:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:XENEXenon Pharmaceuticals Inc
02/05/202421:01GlobeNewswire Inc.Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
16/04/202413:30GlobeNewswire Inc.Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual MeetingNASDAQ:XENEXenon Pharmaceuticals Inc
04/04/202421:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:XENEXenon Pharmaceuticals Inc
12/03/202420:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS DaysNASDAQ:XENEXenon Pharmaceuticals Inc
08/03/202423:47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
08/03/202422:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
08/03/202422:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
08/03/202422:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XENEXenon Pharmaceuticals Inc
08/03/202400:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
08/03/202400:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
05/03/202421:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024NASDAQ:XENEXenon Pharmaceuticals Inc
29/02/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XENEXenon Pharmaceuticals Inc
29/02/202421:01GlobeNewswire Inc.Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
22/02/202421:01GlobeNewswire Inc.Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
14/02/202414:12Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XENEXenon Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:XENE

Your Recent History

BIT
P1X3B6
NLBNPIT1X3B6 20240621 1.1
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved